Comparison of first-line treatments for patients with extensive-stage small cell lung cancer: a systematic review and network meta-analysis

T Zhou, Z Zhang, F Luo, Y Zhao, X Hou, T Liu… - JAMA network …, 2020 - jamanetwork.com
… Conclusions and Relevance The findings of this systematic review and network meta-analysis
suggest that the combination of a PD-L1 inhibitor (durvalumab and atezolizumab) and …

Assessing the relative effectiveness and tolerability of treatments in small cell lung cancer: A network meta-analysis

G Bakalos, M Miligkos, C Doxani, I Mpoulimari… - Cancer …, 2013 - Elsevier
… Then, we performed a network of multiple treatments analysis (network meta-analysis),
involving direct analysis (synthesis of RCTs with the same treatment comparisons) and indirect …

[HTML][HTML] Efficacy and safety of first-line immune checkpoint inhibitors combined with chemotherapy for extensive-stage small cell lung cancer: A network meta-analysis

S Wang, Y Li, Z Liu, W Tian, Y Zeng, J Liu, S Zhang… - Lung Cancer, 2023 - Elsevier
… -stage small cell lung cancer remains unevaluated, and there are no reports to directly
compare the efficacy and safety between different immunotherapy. We performed a network meta-…

… of First‐Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive‐Stage Small Cell Lung Cancer: A Systematic Review and Network Meta …

BC Wang, BY Xiao, PC Li, BH Kuang… - Journal of …, 2020 - Wiley Online Library
… Therefore, in this systematic review and network meta-analysis, we aim to evaluate the
efficacy and safety of combining immunotherapy with chemotherapy and to compare the benefits …

… inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis

U Dafni, Z Tsourti, K Vervita, S Peters - Lung cancer, 2019 - Elsevier
… The objective of the current study is to summarize and compare in a systematic way,
through a Network Meta-Analysis (NMA), all the available to date published information on the …

Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis

H Chen, N Horita, K Ito, H Nagakura… - Therapeutic …, 2020 - journals.sagepub.com
… apply network meta-analysis to assess the obtained data. … PS-, age-based subgroup network
meta-analyses due to the … the last 20 years using network meta-analysis. Although platinum…

[HTML][HTML] ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis

J Elliott, Z Bai, SC Hsieh, SE Kelly, L Chen… - PloS one, 2020 - journals.plos.org
… Data were pooled via meta-analysis and network meta-analysis, and risk of bias was …
inhibitors on overall survival via network meta-analysis. The evidence network for overall survival (…

The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis

PN Aguiar Jr, IL Santoro, H Tadokoro… - …, 2016 - Taylor & Francis
Background Tumor programmed death ligand one (PD-L1) expression has been studied in
several trials in non-small-cell lung cancer. Methods We assessed the potential role of PD-L1 …

… and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta …

YI Zhao, J Liu, X Cai, Z Pan, J Liu, W Yin, H Chen, Z Xie… - Bmj, 2019 - bmj.com
Network metaanalysis, which synthesises evidence from … Previous network metaanalyses
have only partly compared … synthesis, we performed this network meta-analysis of randomised …

[HTML][HTML] First-line treatments for extensive-stage small-cell lung cancer with immune checkpoint inhibitors plus chemotherapy: A network meta-analysis and cost …

S Kang, X Wang, Y Zhang, B Zhang, F Shang… - Frontiers in …, 2022 - frontiersin.org
… We performed the network meta-analysis to obtain the HRs of PFS and OS between the
regimens of ICIs plus chemotherapy based on the Bayesian methods. A fixed-effects model was …